Clinical trials · Minnesota
Idiopathic Inflammatory Myopathies clinical trials in Minnesota
We’re tracking 2 recruiting idiopathic inflammatory myopathies studies with a site in Minnesota — including Phase 1/Phase 2 and Phase 2/Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Minnesota
- NCT06154252RecruitingPhase 2/Phase 3
Study of CABA-201 for active myositis in adults and children
This trial tests a new treatment called CABA-201, which uses your own immune cells modified to attack the overactive cells causing myositis. It is for people with active disease that hasn't improved enough with standard therapies.
Rochester, MinnesotaAges 6–75 - NCT06733935RecruitingPhase 1/Phase 2
Study of NKX019 for immune diseases
This trial tests an investigational cell therapy called NKX019 for people with certain autoimmune diseases like scleroderma, myositis, vasculitis, or rheumatoid arthritis. It aims to see if NKX019 can help control the disease when standard treatments have not worked well enough.
Minneapolis, MinnesotaAges 18–75
Where these studies are running in Minnesota
Institutions with a site for the recruiting idiopathic inflammatory myopathies studies listed above.
- Mayo Clinic
- Nkarta Investigational Site
What taking part in a idiopathic inflammatory myopathies study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Idiopathic Inflammatory Myopathies trials in other states
Common questions
- Are there idiopathic inflammatory myopathies clinical trials in Minnesota?
- Yes. We're currently tracking 2 recruiting idiopathic inflammatory myopathies studies with a site in Minnesota, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a idiopathic inflammatory myopathies study in Minnesota?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Minnesota to take part?
- Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a idiopathic inflammatory myopathies trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New idiopathic inflammatory myopathies studies open in Minnesota regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.